The inhibitory effect of GMF on inflammatory factor NF-κB-mediated cancer progression was also revealed by decreasing the oncogenic potential of TNF-α-mediated cell migration, invasion, and EMT after GMF treatment of the SW620 cells. Here, NFKB1 is linked to cancer.